ASB Consultores LLC reduced its holdings in shares of Morgan Stanley (NYSE:MS – Free Report) by 7.3% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 4,944 shares of the financial services provider’s stock after selling 392 shares during the quarter. ASB Consultores LLC’s holdings in Morgan Stanley were worth $515,000 at the end of the most recent reporting period.
Several other large investors have also bought and sold shares of the business. Capital International Investors boosted its stake in shares of Morgan Stanley by 16.3% in the 1st quarter. Capital International Investors now owns 28,481,070 shares of the financial services provider’s stock valued at $2,681,778,000 after purchasing an additional 3,981,528 shares in the last quarter. Bank of New York Mellon Corp grew its stake in shares of Morgan Stanley by 2.4% during the second quarter. Bank of New York Mellon Corp now owns 12,875,677 shares of the financial services provider’s stock worth $1,251,387,000 after buying an additional 303,654 shares during the last quarter. Legal & General Group Plc increased its holdings in shares of Morgan Stanley by 2.0% during the second quarter. Legal & General Group Plc now owns 10,597,493 shares of the financial services provider’s stock worth $1,029,970,000 after buying an additional 212,551 shares in the last quarter. Dimensional Fund Advisors LP lifted its stake in shares of Morgan Stanley by 2.8% in the 2nd quarter. Dimensional Fund Advisors LP now owns 8,834,372 shares of the financial services provider’s stock valued at $858,573,000 after acquiring an additional 242,896 shares during the last quarter. Finally, Boston Partners boosted its holdings in shares of Morgan Stanley by 0.8% during the 1st quarter. Boston Partners now owns 7,151,492 shares of the financial services provider’s stock valued at $672,969,000 after acquiring an additional 57,104 shares in the last quarter. 84.19% of the stock is owned by institutional investors and hedge funds.
Morgan Stanley Price Performance
Shares of NYSE MS opened at $116.14 on Tuesday. The firm has a market capitalization of $188.75 billion, a P/E ratio of 17.68, a P/E/G ratio of 1.09 and a beta of 1.34. The firm’s 50-day moving average price is $107.29 and its 200-day moving average price is $101.52. The company has a current ratio of 0.78, a quick ratio of 0.78 and a debt-to-equity ratio of 2.96. Morgan Stanley has a 1-year low of $73.96 and a 1-year high of $121.45.
Morgan Stanley Announces Dividend
Insider Buying and Selling at Morgan Stanley
In other news, Director Stephen J. Luczo sold 60,000 shares of the business’s stock in a transaction dated Thursday, October 17th. The shares were sold at an average price of $119.17, for a total transaction of $7,150,200.00. Following the completion of the sale, the director now directly owns 138,363 shares of the company’s stock, valued at $16,488,718.71. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Insiders own 0.24% of the company’s stock.
Wall Street Analysts Forecast Growth
MS has been the subject of several research reports. Oppenheimer downgraded Morgan Stanley from an “outperform” rating to a “market perform” rating in a research report on Wednesday, July 17th. Wells Fargo & Company raised their price objective on shares of Morgan Stanley from $95.00 to $107.00 and gave the company an “underweight” rating in a report on Thursday, October 17th. Royal Bank of Canada boosted their target price on shares of Morgan Stanley from $108.00 to $122.00 and gave the stock a “sector perform” rating in a report on Thursday, October 17th. Hsbc Global Res raised shares of Morgan Stanley from a “hold” rating to a “strong-buy” rating in a research note on Friday, October 4th. Finally, The Goldman Sachs Group boosted their price objective on shares of Morgan Stanley from $106.00 to $121.00 and gave the stock a “neutral” rating in a research note on Thursday, October 17th. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $109.24.
Check Out Our Latest Stock Report on MS
About Morgan Stanley
Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals in the Americas, Europe, the Middle East, Africa, and Asia. It operates through Institutional Securities, Wealth Management, and Investment Management segments.
Featured Stories
- Five stocks we like better than Morgan Stanley
- What is the Dow Jones Industrial Average (DJIA)?
- Why Warren Buffett’s 1999 Market Warning Still Matters Today
- Election Stocks: How Elections Affect the Stock Market
- Medicare Advantage Costs Surge: How These 2 Insurers Are Thriving
- What Investors Need to Know to Beat the Market
- Mobileye’s Recovery Steadily Gains Traction with Novel AI
Want to see what other hedge funds are holding MS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Morgan Stanley (NYSE:MS – Free Report).
Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with MarketBeat.com's FREE daily email newsletter.